Published in Pain on July 20, 2011
A Pilot Study of TMS Effects on Pain and Depression in Patients With Fibromyalgia | NCT00523302
Use of Repetitive Transcranial Magnetic Stimulation to Augment Hypnotic Analgesia | NCT02969707
Trigeminal Nerve Stimulation (TNS) in the Treatment of Fibromyalgia (TNS-FMA) | NCT02120690
Transcranial magnetic stimulation of the brain: guidelines for pain treatment research. Pain (2015) 2.11
The expanding evidence base for rTMS treatment of depression. Curr Opin Psychiatry (2013) 1.29
Widespread modulation of cerebral perfusion induced during and after transcranial direct current stimulation applied to the left dorsolateral prefrontal cortex. J Neurosci (2013) 1.19
Transcranial magnetic stimulation in the treatment of chronic widespread pain: a randomized controlled study. J ECT (2015) 0.75
rTMS of the prefrontal cortex has analgesic effects on neuropathic pain in subjects with spinal cord injury. Spinal Cord (2016) 0.75
Reduction of pain thresholds in fibromyalgia after very low-intensity magnetic stimulation: a double-blinded, randomized placebo-controlled clinical trial. Pain Res Manag (2013) 0.75
Mental Health Comorbidities in Pediatric Chronic Pain: A Narrative Review of Epidemiology, Models, Neurobiological Mechanisms and Treatment. Children (Basel) (2016) 0.75
Repetitive transcranial magnetic stimulation for chronic pain: time to evolve from exploration to confirmation? Pain (2011) 0.75
A rating scale for depression. J Neurol Neurosurg Psychiatry (1960) 90.89
The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum (1990) 27.50
Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore (1994) 16.38
Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol (2009) 11.59
Placebo-induced changes in FMRI in the anticipation and experience of pain. Science (2004) 8.33
The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum (1995) 7.97
The fibromyalgia impact questionnaire: development and validation. J Rheumatol (1991) 5.94
Placebo and opioid analgesia-- imaging a shared neuronal network. Science (2002) 4.57
Transcranial magnetic stimulation: a primer. Neuron (2007) 3.77
Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J Neurosci (1999) 3.19
Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry (2010) 3.14
Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes. Semin Arthritis Rheum (2007) 2.78
A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. J Rheumatol (2008) 2.67
Intrinsic brain connectivity in fibromyalgia is associated with chronic pain intensity. Arthritis Rheum (2010) 2.52
Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J Neurosci (2001) 2.49
A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum (2004) 2.48
The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial. J Rheumatol (2009) 2.46
Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain (2005) 2.26
A safety screening questionnaire for transcranial magnetic stimulation. Clin Neurophysiol (2001) 2.20
Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis. Psychol Med (2008) 2.00
Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther (2008) 1.86
Evidence of dysfunctional pain inhibition in Fibromyalgia reflected in rACC during provoked pain. Pain (2009) 1.72
Central sensitization: a biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome. Clin Rheumatol (2006) 1.54
Cortico-cortical connectivity of the human mid-dorsolateral frontal cortex and its modulation by repetitive transcranial magnetic stimulation. Eur J Neurosci (2001) 1.49
Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and metaanalysis. Can J Psychiatry (2008) 1.40
Cerebrospinal fluid levels of opioid peptides in fibromyalgia and chronic low back pain. BMC Musculoskelet Disord (2004) 1.27
Estimating resting motor thresholds in transcranial magnetic stimulation research and practice: a computer simulation evaluation of best methods. J ECT (2006) 1.27
Loss of expectation-related mechanisms in Alzheimer's disease makes analgesic therapies less effective. Pain (2006) 1.24
Prefrontal cortex modulates placebo analgesia. Pain (2009) 1.21
Development and evaluation of a portable sham transcranial magnetic stimulation system. Brain Stimul (2008) 1.15
Transcranial magnetic stimulation reduces pain in patients with major depression: a sham-controlled study. J Nerv Ment Dis (2007) 1.15
Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum (2010) 1.13
Toward the identification of symptom patterns in people with fibromyalgia. Arthritis Rheum (2009) 1.07
Comparison of "standard" and "navigated" procedures of TMS coil positioning over motor, premotor and prefrontal targets in patients with chronic pain and depression. Neurophysiol Clin (2010) 1.06
Slow-frequency rTMS reduces fibromyalgia pain. Pain Med (2006) 1.06
A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia. J Rheumatol (2010) 1.02
Effects of unilateral repetitive transcranial magnetic stimulation of the motor cortex on chronic widespread pain in fibromyalgia. Brain (2007) 1.00
Rapid-rate transcranial magnetic stimulation and ECT. Convuls Ther (1994) 0.98
Alteration of cortical excitability in patients with fibromyalgia. Pain (2010) 0.94
Decreasing procedural pain over time of left prefrontal rTMS for depression: initial results from the open-label phase of a multi-site trial (OPT-TMS). Brain Stimul (2009) 0.92
Heterogeneity within the fibromyalgia population: theoretical implications of variable tender point severity ratings. J Rheumatol (2009) 0.87
Changing cortical excitability with low-frequency magnetic stimulation. Neurology (2001) 0.83
Low-frequency transcranial magnetic stimulation in patients with fibromyalgia and major depression. Pain Med (2009) 0.82
Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry (2007) 5.59
Special articles: guidelines for performing ultrasound guided vascular cannulation: recommendations of the American Society of Echocardiography and the Society Of Cardiovascular Anesthesiologists. Anesth Analg (2011) 3.08
Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr (2013) 2.71
Differential brain activity in alcoholics and social drinkers to alcohol cues: relationship to craving. Neuropsychopharmacology (2004) 2.69
Guidelines for performing ultrasound guided vascular cannulation: recommendations of the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr (2011) 2.68
Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology (2008) 2.31
Regional cerebral glucose utilization in patients with a range of severities of unipolar depression. Biol Psychiatry (2002) 2.26
Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry (2005) 2.24
VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology (2006) 2.24
Decreased brain activation during a working memory task at rested baseline is associated with vulnerability to sleep deprivation. Sleep (2005) 2.04
Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol Psychiatry (2005) 1.90
A potential role for thalamocingulate circuitry in human maternal behavior. Biol Psychiatry (2002) 1.81
A double blind study showing that two weeks of daily repetitive TMS over the left or right temporoparietal cortex reduces symptoms in patients with schizophrenia who are having treatment-refractory auditory hallucinations. Neurosci Lett (2004) 1.79
Neural correlates of speech anticipatory anxiety in generalized social phobia. Neuroreport (2004) 1.69
Repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex reduces nicotine cue craving. Biol Psychiatry (2013) 1.63
Vagus nerve stimulation acutely alters food craving in adults with depression. Appetite (2006) 1.61
Feasibility, safety, and effectiveness of transcranial direct current stimulation for decreasing post-ERCP pain: a randomized, sham-controlled, pilot study. Gastrointest Endosc (2011) 1.58
Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry (2005) 1.57
Aprotinin in cardiac surgery: a review of conventional and novel mechanisms of action. Anesth Analg (2007) 1.57
Consensus paper: combining transcranial stimulation with neuroimaging. Brain Stimul (2009) 1.54
Standardized preoperative corticosteroid treatment in neonates undergoing cardiac surgery: results from a randomized trial. J Thorac Cardiovasc Surg (2011) 1.50
Beyond neural cubism: promoting a multidimensional view of brain disorders by enhancing the integration of neurology and psychiatry in education. Acad Med (2015) 1.40
Detecting deception using functional magnetic resonance imaging. Biol Psychiatry (2005) 1.38
Volitional reduction of anterior cingulate cortex activity produces decreased cue craving in smoking cessation: a preliminary real-time fMRI study. Addict Biol (2012) 1.36
Neural correlates of craving and resisting craving for tobacco in nicotine dependent smokers. Addict Biol (2011) 1.30
Meta-analysis of left prefrontal repetitive transcranial magnetic stimulation (rTMS) to treat depression. J Psychiatr Pract (2002) 1.30
Repetitive transcranial magnetic stimulation of the prefrontal cortex in depression. Exp Neurol (2009) 1.28
Postoperative left prefrontal repetitive transcranial magnetic stimulation reduces patient-controlled analgesia use. Anesthesiology (2006) 1.28
Estimating resting motor thresholds in transcranial magnetic stimulation research and practice: a computer simulation evaluation of best methods. J ECT (2006) 1.27
Emotion facilitates action: a transcranial magnetic stimulation study of motor cortex excitability during picture viewing. Psychophysiology (2007) 1.26
Reducing pain and unpleasantness during repetitive transcranial magnetic stimulation. J ECT (2006) 1.22
A pilot study of the tolerability and effects of high-definition transcranial direct current stimulation (HD-tDCS) on pain perception. J Pain (2011) 1.20
Serial vagus nerve stimulation functional MRI in treatment-resistant depression. Neuropsychopharmacology (2007) 1.19
Can left prefrontal rTMS be used as a maintenance treatment for bipolar depression? Depress Anxiety (2004) 1.18
Decreased cortical response to verbal working memory following sleep deprivation. Sleep (2005) 1.18
Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes. Biol Psychiatry (2002) 1.17
Durability of antidepressant response to vagus nerve stimulation (VNS). Int J Neuropsychopharmacol (2007) 1.16
Development and evaluation of a portable sham transcranial magnetic stimulation system. Brain Stimul (2008) 1.15
An efficient and accurate new method for locating the F3 position for prefrontal TMS applications. Brain Stimul (2009) 1.15
Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: a pilot study of acute safety and efficacy. Bipolar Disord (2003) 1.15
Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. Anesth Analg (2014) 1.15
A review of functional neuroimaging studies of vagus nerve stimulation (VNS). J Psychiatr Res (2003) 1.14
Cerebral blood flow changes during vagus nerve stimulation for depression. Psychiatry Res (2006) 1.13
Focal electrical stimulation as a sham control for repetitive transcranial magnetic stimulation: Does it truly mimic the cutaneous sensation and pain of active prefrontal repetitive transcranial magnetic stimulation? Brain Stimul (2008) 1.13
Intermittent "real-time" fMRI feedback is superior to continuous presentation for a motor imagery task: a pilot study. J Neuroimaging (2010) 1.12
Fifteen minutes of left prefrontal repetitive transcranial magnetic stimulation acutely increases thermal pain thresholds in healthy adults. Pain Res Manag (2007) 1.11
More lateral and anterior prefrontal coil location is associated with better repetitive transcranial magnetic stimulation antidepressant response. Biol Psychiatry (2009) 1.11
Are individual differences in fatigue vulnerability related to baseline differences in cortical activation? Behav Neurosci (2005) 1.11
Regional brain activation during meditation shows time and practice effects: an exploratory FMRI study. Evid Based Complement Alternat Med (2007) 1.09
Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial. World Psychiatry (2015) 1.09
Cortical and subcortical brain effects of transcranial magnetic stimulation (TMS)-induced movement: an interleaved TMS/functional magnetic resonance imaging study. Biol Psychiatry (2005) 1.08
Acute left prefrontal transcranial magnetic stimulation in depressed patients is associated with immediately increased activity in prefrontal cortical as well as subcortical regions. Biol Psychiatry (2004) 1.07
A pilot study of functional magnetic resonance imaging brain correlates of deception in healthy young men. J Neuropsychiatry Clin Neurosci (2004) 1.06
Reduction of cue-induced craving through realtime neurofeedback in nicotine users: the role of region of interest selection and multiple visits. Psychiatry Res (2013) 1.06
Vagus nerve stimulation (VNS) synchronized BOLD fMRI suggests that VNS in depressed adults has frequency/dose dependent effects. J Psychiatr Res (2002) 1.05
Cloninger's temperament and character dimensions of personality in patients with major depressive disorder. Compr Psychiatry (2009) 1.03
Safety and benefits of distance-adjusted prefrontal transcranial magnetic stimulation in depressed patients 55-75 years of age: a pilot study. Depress Anxiety (2004) 1.03
Endothelin-A receptor inhibition after cardiopulmonary bypass: cytokines and receptor activation. Ann Thorac Surg (2008) 1.03
Age, sex and laterality effects on cerebral glucose metabolism in healthy adults. Psychiatry Res (2002) 1.03
A replication study of the neural correlates of deception. Behav Neurosci (2004) 1.02
Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial. J Clin Psychiatry (2008) 1.01
Left prefrontal-repetitive transcranial magnetic stimulation (rTMS) and regional cerebral glucose metabolism in normal volunteers. Psychiatry Res (2002) 1.00
Significant analgesic effects of one session of postoperative left prefrontal cortex repetitive transcranial magnetic stimulation: a replication study. Brain Stimul (2008) 1.00
Motor threshold in transcranial magnetic stimulation: the impact of white matter fiber orientation and skull-to-cortex distance. Hum Brain Mapp (2009) 1.00
Cerebral cortex plasticity after 90 days of bed rest: data from TMS and fMRI. Aviat Space Environ Med (2010) 1.00
Tolerability and safety of high daily doses of repetitive transcranial magnetic stimulation in healthy young men. J ECT (2006) 0.98
Sustained reduction of nicotine craving with real-time neurofeedback: exploring the role of severity of dependence. Nicotine Tob Res (2013) 0.98
Decision analysis of the cost-effectiveness of repetitive transcranial magnetic stimulation versus electroconvulsive therapy for treatment of nonpsychotic severe depression. CNS Spectr (2004) 0.97
Regional brain activity in women grieving a romantic relationship breakup. Am J Psychiatry (2004) 0.95
Transcranial magnetic stimulation in the treatment of substance addiction. Ann N Y Acad Sci (2014) 0.94
Interleaved transcranial magnetic stimulation/functional MRI confirms that lamotrigine inhibits cortical excitability in healthy young men. Neuropsychopharmacology (2004) 0.94
WFSBP Guidelines on Brain Stimulation Treatments in Psychiatry. World J Biol Psychiatry (2010) 0.94
A single 20 mg dose of the full D1 dopamine agonist dihydrexidine (DAR-0100) increases prefrontal perfusion in schizophrenia. Schizophr Res (2007) 0.94
Naloxone-reversible modulation of pain circuitry by left prefrontal rTMS. Neuropsychopharmacology (2013) 0.93
Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery. J Thorac Cardiovasc Surg (2011) 0.93
Vagus nerve stimulation for the treatment of depression and other neuropsychiatric disorders. Expert Rev Neurother (2007) 0.93
Noninvasive cortical modulation of experimental pain. Pain (2012) 0.93
Endogenous opioids mediate left dorsolateral prefrontal cortex rTMS-induced analgesia. Pain (2012) 0.92